Scrip Asia 100 - Bloc building
This article was originally published in Scrip
ASEAN nations know that they need to get their regulatory systems in line before they can compete on the global stage. Phil Greenfield explains how market harmonisation will pave the way for better access to medicines as well as assuage the concerns of innovator pharma.
You may also be interested in...
Deals give the company access to technologies to increase the accuracy of multi-cancer blood tests.
Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.
The company is the second big medtech to announce a major investment in R&D in the country in 2020.